XML 39 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity - USD ($)
Series A Convertible Preferred Stock
Preferred Stock
Series A Convertible Preferred Stock
Common Stock
ATM offering
Common Stock
Additional Paid-in capital
ATM offering
Additional Paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
ATM offering
Total
Temporary equity, beginning balance (in shares) at Dec. 31, 2023 56,227                  
Temporary equity, beginning balance at Dec. 31, 2023 $ 1,311,063                  
Temporary equity, ending balance (in shares) at Dec. 31, 2024 56,227 56,227                
Temporary equity, ending balance at Dec. 31, 2024 $ 1,311,063 $ 1,311,063                
Equity, beginning balance at Dec. 31, 2023       $ 3,736   $ 335,644,204 $ (10,611,273) $ (308,083,161)   $ 16,953,506
Equity, beginning balance (in shares) at Dec. 31, 2023       3,736,673            
Increase (Decrease) in Stockholders' Equity                    
Vesting of restricted stock units       $ 11   (11)        
Vesting of restricted stock units (in shares)       10,518            
Issuance of common stock and pre-funded warrants, net     $ 41 $ 1,688 $ 134,364 14,685,802     $ 134,405 14,687,490
Issuance of common stock and pre-funded warrants, net (in shares)     41,152 1,687,712            
Issuance of common stock to consultants       $ 5   17,430       17,435
Issuance of common stock to consultants (in shares)       5,000            
Stock-based compensation           489,436       489,436
Foreign currency translation             (16,106)     (16,106)
Net Income (Loss)               (12,958,711)   (12,958,711)
Equity, ending balance at Dec. 31, 2024       $ 5,481   350,971,225 (10,627,379) (321,041,872)   19,307,455
Equity, ending balance (in shares) at Dec. 31, 2024       5,481,055            
Increase (Decrease) in Temporary Equity                    
Conversion of preferred stock to common stock $ (583,702)                  
Conversion of preferred stock to common stock (in shares) (25,033)                  
Temporary equity, ending balance (in shares) at Dec. 31, 2025 31,194 31,194                
Temporary equity, ending balance at Dec. 31, 2025 $ 727,361 $ 727,361                
Increase (Decrease) in Stockholders' Equity                    
Vesting of restricted stock units       $ 17   (17)        
Vesting of restricted stock units (in shares)       17,154            
Issuance of common stock and pre-funded warrants, net     $ 1,338 $ 26 $ 1,913,887 2,724,896     $ 1,915,225 2,724,922
Issuance of common stock and pre-funded warrants, net (in shares)     1,337,948 26,459            
Issuance of common stock to consultants       $ 28   39,022       39,050
Issuance of common stock to consultants (in shares)       27,500            
Exercise of pre-funded warrants       $ 1,290   (1,199)       91
Exercise of pre-funded warrants (in shares)       1,289,906            
Stock-based compensation           478,141       478,141
Foreign currency translation             (7,335)     (7,335)
Conversion of preferred stock into common stock       $ 12   583,690       583,702
Conversion of preferred stock into common stock (in shares)       12,516            
Net Income (Loss)               (12,599,569)   (12,599,569)
Equity, ending balance at Dec. 31, 2025       $ 8,192   $ 356,709,645 $ (10,634,714) $ (333,641,441)   $ 12,441,682
Equity, ending balance (in shares) at Dec. 31, 2025       8,192,538